Apple has achieved a major milestone in digital health innovation, with the Apple Watch Series 11 receiving approval from the U.S. Food and Drug Administration (FDA) for its hypertension detection feature. This advancement positions the smartwatch as more than a fitness accessory, evolving it into a certified medical tool for monitoring cardiovascular health. By integrating advanced sensors and AI-driven algorithms, Apple aims to empower users to detect early signs of high blood pressure, potentially reducing risks associated with stroke and heart disease.